PURDUE PHARMA, LP for PURDUE PHARMA LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
s.2839Comprehensive Addiction and Recovery Act -Line Extension as relates to Abuse Deterrent Formulations -Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
s.2839Comprehensive Addiction and Recovery Act -Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Line Extension as relates to Abuse Deterrent Formulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Alcohol and Drug Abuse ALC
s.2839Comprehensive Addiction and Recovery Act -Disposal of Drugs -Harmonization of abuse deterrent formulations between US FDA & Health Canada -Hearings related to prescription drug abuse and prevention -Line Extension as relates to Abuse Deterrent Formulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Environment/Superfund ENV
Lower Passaic River EPA Remedial Design
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.